DrugPatentWatch Database Preview

CARDURA Drug Profile

« Back to Dashboard

When do Cardura patents expire, and when can generic versions of Cardura launch?

Cardura is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.

Summary for CARDURA

US Patents:	0
Applicants:	1
NDAs:	2
Suppliers / Packagers:	4
Bulk Api Vendors:	79
Clinical Trials:	9
Patent Applications:	1,503
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CARDURA
Drug Sales Revenues:	Drug sales revenues for CARDURA
DailyMed Link:	CARDURA at DailyMed

Pharmacology for CARDURA

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for CARDURA

Adrenergic alpha-1 Receptor Antagonists

Antihypertensive Agents

Synonyms for CARDURA

(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate

[1,4]dioxin-2-yl)methanone methanesulfonate

[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone; methanesulfonic acid

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-2-yl)methanone; methanesulfonic acid

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone; methanesulfonic acid

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanonemethanesulfonic acid

1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(1,4-BENZODIOXAN-2-YLCARBONYL) PIPERAZINE METHANESULFONATE

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazine monomethanesulfonate

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzoldioxan-2-ylcarbonyl)piperazine methanesulfonate

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(1,4-benzodioxan-2-yl)carbonyl]piperazine Methanesulfonate

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate

2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; methanesulfonic acid

2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine mesylate

2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; methanesulfonic acid

4-Amino-2-[4-(1,4-benzodioxan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazoline methanesulfonate

74191-85-8 (Parent)

77883-43-3

91D858

AB0008587

AB2000045

AC-6848

AC1L1Y5G

AC1Q4GSV

AC1Q4GT3

AKOS015895371

Alfadil

AN-9627

ANW-42738

BCP12163

Benur

C23H25N5O5.CH4O3S

C24H29N5O8S

Cardenalin

Cardoral

Cardoxan

Cardular

Cardular PP

Cardular Uro

Cardura (TN)

Cardura XL

Cardura;Carduran;Cardura XL

Carduran

Carduran Neo

CAS-77883-43-3

CCG-213583

CHEBI:4709

CHEMBL1200561

CPD000058441

CS-1830

CTK7B4527

D 9815

D00608

D4126

Dedralen

Diblocin

Diblocin PP

Diblocin Uro

Doksura

Dosin

Doxaben

Doxazocine

Doxazomerck

Doxazosin (mesylate)

Doxazosin AZU

Doxazosin mesilate

Doxazosin mesilate (JP17)

Doxazosin mesilate, European Pharmacopoeia (EP) Reference Standard

Doxazosin mesylate

Doxazosin mesylate (USAN)

Doxazosin mesylate [USAN:USP]

Doxazosin mesylate [USAN]

doxazosin mesylate salt

Doxazosin mesylate, >=97% (HPLC), powder

Doxazosin mesylate, United States Pharmacopeia (USP) Reference Standard

Doxazosin Mesylate,(S)

Doxazosinmesylate

Doxolbran

DSSTox_CID_25598

DSSTox_GSID_45598

DSSTox_RID_80991

DTXSID5045598

Duracin

EN300-53021

EU-0100474

FT-0625592

HMS1570L17

HMS2093J14

HMS2097L17

HMS2230L18

HMS3261O10

HMS3372C03

HMS3654J15

HMS3714L17

HSDB 7082

HY-B0098A

I06-0611

J10294

Kaltensif

KS-1052

LP00474

LS-110229

MFCD00216023

MLS000028455

MLS000120399

MLS001148153

MLS002222292

MLS006011977

MolPort-003-983-427

NCGC00016146-02

NCGC00017136-01

NCGC00018158-09

NCGC00093884-01

NCGC00261159-01

NE52844

Normathen

NSC-759284

NSC759284

Opera_ID_1881

Pharmakon1600-01505976

piperazin-1-yl)(2,3-dihydrobenzo[b]

Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-, monomethanesulfonate

Prestwick_1026

Progandol

Prostadilat

PubChem2385

RW2756

s1324

SAM002589903

SCHEMBL42621

SMR000058441

SR-01000003045

SR-01000003045-2

SR-01000003045-4

SR-01000003045-8

Supressin

SW197099-3

Tensiobas

TL8005338

Tonocardin

Tox21_110796

Tox21_110796_1

Tox21_500474

UK 33,274-27

UK-33,274-27

UK-33274

UK-33274-27

UK-3327427

VJECBOKJABCYMF-UHFFFAOYSA-N

Z1259084903

US Patents and Regulatory Information for CARDURA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-001	Nov 2, 1990	AB	RX	Yes	Yes
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-004	Nov 2, 1990	AB	RX	Yes	No
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-002	Nov 2, 1990	AB	RX	Yes	No
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-003	Nov 2, 1990	AB	RX	Yes	No
Pfizer	CARDURA XL	doxazosin mesylate	TABLET, EXTENDED RELEASE;ORAL	021269-002	Feb 22, 2005		RX	Yes	Yes
Pfizer	CARDURA XL	doxazosin mesylate	TABLET, EXTENDED RELEASE;ORAL	021269-001	Feb 22, 2005		RX	Yes	No

Expired US Patents for CARDURA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-003	Nov 2, 1990
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-001	Nov 2, 1990
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-004	Nov 2, 1990
Pfizer	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-002	Nov 2, 1990